RO5323441

DRUG2 trials

Sponsors

Hoffmann-La Roche

Conditions

Carcinoma, HepatocellularColorectal Cancer, Ovarian Cancer

Phase 1

A Dose-finding Study of RO5323441 in Patients With Metastatic Treatment-Refractory Colorectal or Ovarian Cancer

CompletedNCT01148758

Hoffmann-La RocheColorectal Cancer, Ovarian Cancer

Start: 2010-05-31End: 2010-09-30Updated: 2016-11-02

A Dose-Finding and Exploratory Study of RO5323441 in Combination With Sorafenib in Patients With Hepatocellular Carcinoma

CompletedNCT01308723

Hoffmann-La RocheCarcinoma, Hepatocellular

Start: 2011-03-31End: 2012-01-31Updated: 2016-11-02